All key figures as of December 31. If you're looking for further financial information, please visit our financial reports page.
|$1,000 except per share data||2016||2015||2014||2013||2012|
|Basic earnings per share (EPS)*||0.34||0.56||0.50||0.28||0.54|
|Diluted earnings per share (EPS)*||0.34||0.55||0.48||0.27||0.52|
|Number of shares (in thousands)|
|Common shares used to compute basic net income1||234,800||233,483||232,644||234,000||235,582|
|Common shares used to compute diluted net income2||238,993||238,647||242,806||243,400||242,020|
|Cash flow from operations||341,602||317,497||287,965||258,957||244,880|
|Capital expenditures for property, plant and equipment||74,536||97,778||86,591||84,468||101,996|
|Free cash flow3||267,066||219,719||201,374||174,489||142,884|
|Cash and cash equivalents||439,180||290,011||392,667||330,303||394,037|
|Total long-term liabilities, including current portion||1,393,668||1,343,616||1,490,114||1,024,389||1,094,934|
1 Weighted average number of common shares used to compute basic net income per common share
2 Weighted average number of common shares used to compute diluted net income per common share
3 Free cash flow(cash flow from operations less capital expenditures)
* Attributable to the owners of QIAGEN N.V.